ILADS conference 2014


The project partner BCA organized the International Lyme and Associated Diseases Society (ILADS) conference for 2014.
The meeting took place on April 25th and April 26th 2014 in Augsburg (Germany).

The conference welcomed 115 participants overall and was supported by 11 exhibitors and 13 speakers who exposed current information about the topic.
The BCA-clinic in Augsburg organized the ILADS Conference on site.
The day before the official inauguration, Dr. Carsten Nicolaus and Dr. Armin Schwarzbach welcomed approximately 30 participants within the premises of the BCA-clinic, where they were able to learn about the possibilities of diagnosis with Infectolab (partner of the BCA-clinic) and therapies in the BCA-clinic.

Project participants Dr Carsten and Dr Armin both did presentations relevant for raising awareness on Lyme disease and on diagnostic methodologies.
Dr Armin Schwarzbach, informed about the interpretation and application of laboratory tests when treating tick-borne disease.
He highlighted the importance of preanalytics for lab results. He differentiated various tests such as PCR, ELISA and immunoblot, CD-57-NK cells as well as LTT-Elispot in reference to multisystem diseases.

Dr Carsten Nicolaus, presented a European view of the epidemiology and pathogenesis of Lyme disease.
The varied co-infections were put in the spotlight. He presented thoroughly the different tick-borne co-infections, but also those transmitted or caught otherwise (additional infections).
He exposed the symptoms of those infections and highlighted the difficulty of diagnosis due to the overlapping symptoms.
At last, he presented the combination therapy he applies for multiple infections.

Dr Armin Schwarzbach, did another presentation where he explained the limitations of the laboratory diagnostics in Lyme disease.
He highlighted the low sensitivity of ELISA and Immunoblot-tests.
To compensate this, additional cellular immune system tests should be carried out: LTT-Elispot and CD-57-NK-cells as laboratory cells.
In the second part of his presentation, he explained the possibilities to use the laboratory tests for the diagnostics of co-infections and additional infections.